Showing results (681-690 of 833) with videos related to
Sort By:
Pageof 84
Diabetes Care|December 6, 2008
Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) studySigne W Worm, Caroline A Sabin, Peter Reiss, et al.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 9, 1997
Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study GroupJ D Lundgren, A N Phillips, S Vella, et al.The Journal of Infectious Diseases|August 4, 2016
Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D StudyLene Ryom, Jens D Lundgren, Mike Ross, et al.Journal of the International AIDS Society|October 20, 2012
Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) studyKathy Petoumenos, Signe W Worm, Eric Fontas, et al.The Journal of Infectious Diseases|October 24, 2007
Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patientsFrancesca Ceccherini-Silberstein, Alessandro Cozzi-Lepri, Lidia Ruiz, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2012
Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs studyHelen Kovari, Caroline A Sabin, Bruno Ledergerber, et al.Journal of the International AIDS Society|March 7, 2018
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D StudyCamilla I Hatleberg, Lene Ryom, Wafaa El-Sadr, et al.The Journal of Infectious Diseases|February 5, 2014
Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected personsLeah Shepherd, Jean-Claude Souberbielle, Jean-Philippe Bastard, et al.AIDS (London, England)|October 27, 2016
The per-protocol effect of immediate versus deferred antiretroviral therapy initiationSara Lodi, Shweta Sharma, Jens D Lundgren, et al.AIDS (London, England)|October 4, 2008
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignanciesAntonella d'Arminio Monforte, Donald Abrams, Christian Pradier, et al.Pageof 84